Gentera. de Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Gentera. de heeft totale activa van MX$99.0B en een totaal eigen vermogen van MX$31.4B. De totale deposito's bedragen MX$21.4B, en de totale leningen bedragen MX$69.5B.

Belangrijke informatie

3.2x

Verhouding activa / eigen vermogen

n/a

Nettorentemarge

Totaal deposito's	Mex$21.35b
Verhouding leningen/deposito's	Hoog
Slechte leningen	3.5%
Voorziening voor dubieuze leningen	Voldoende
Huidige ratio	Laag
Geldmiddelen en kasequivalenten	Mex$9.82b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Gentera, S.A.B. de C.V. (BMV:GENTERA) Released Earnings Last Week And Analysts Lifted Their Price Target To Mex$13.55

Mar 01

Is Gentera, S.A.B. de C.V. (BMV:GENTERA) Popular Amongst Institutions?

Feb 15

Gentera. de (BMV:GENTERA) Share Prices Have Dropped 72% In The Last Five Years

Dec 25

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse financiële instellingen

Activa niveau: De Vermogen/vermogensverhouding ( 3.2 x) GENTERA * is laag.

Voorziening voor slechte leningen: GENTERA * heeft een voldoende voorziening voor slechte leningen ( 231 %).

Laag risico verplichtingen: 68% van de verplichtingen van GENTERA * bestaan voornamelijk uit financieringsbronnen met een hoger risico.

Leenniveau: GENTERA * heeft een passend niveau van Leningen/activa-ratio ( 70% ).

Laag risico deposito's: De leningen-depositoverhouding ( 326% ) van GENTERA * } is hoog.

Niveau van slechte leningen: GENTERA * heeft een hoog niveau van slechte leningen ( 3.5 %).

Gentera. de Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

New minor risk - Share price stability

Now 20% undervalued

Dividend of Mex$0.60 announced

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Now 20% undervalued

Gentera, S.A.B. de C.V. to Report Q3, 2024 Results on Oct 23, 2024

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

New minor risk - Share price stability

Now 22% undervalued after recent price drop

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 20% undervalued after recent price drop

Upcoming dividend of Mex$0.58 per share at 2.9% yield

Third quarter 2023 earnings: Revenues exceed analyst expectations

Gentera, S.A.B. de C.V. to Report Q3, 2023 Results on Oct 25, 2023

Second quarter 2023 earnings released

Do Gentera. de's (BMV:GENTERA) Earnings Warrant Your Attention?

Gentera, S.A.B. de C.V. to Report Q2, 2023 Results on Jul 26, 2023

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

With EPS Growth And More, Gentera. de (BMV:GENTERA) Makes An Interesting Case

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Is Now The Time To Put Gentera. de (BMV:GENTERA) On Your Watchlist?

Consensus EPS estimates increase by 12%

Third quarter 2022 earnings released: EPS: Mex$0.83 (vs Mex$0.53 in 3Q 2021)

Gentera, S.A.B. de C.V. Revises Financial Guidance for the Full Year of Fiscal 2022

Now 21% undervalued

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Now 22% undervalued

Gentera, S.A.B. de C.V. to Report Q3, 2022 Results on Oct 26, 2022

Now 22% undervalued

Insufficient new directors

Now 21% undervalued

Price target increased to Mex$19.84

Insufficient new directors

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Gentera, S.A.B. de C.V. to Report Q1, 2022 Results on Apr 27, 2022

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased to Mex$17.45

Gentera, S.A.B. de C.V. (BMV:GENTERA *) acquired additional 6.04% stake in ConCrédito.

Third quarter 2021 earnings released: EPS Mex$0.53 (vs Mex$1.26 loss in 3Q 2020)

First quarter 2021 earnings released: EPS Mex$0.20 (vs Mex$0.49 in 1Q 2020)

Full year 2020 earnings released: Mex$1.06 loss per share (vs Mex$2.11 profit in FY 2019)

Revenue beats expectations, earnings disappoint

Gentera, S.A.B. de C.V. (BMV:GENTERA) Released Earnings Last Week And Analysts Lifted Their Price Target To Mex$13.55

New 90-day high: Mex$10.64

Is Gentera, S.A.B. de C.V. (BMV:GENTERA) Popular Amongst Institutions?

Gentera. de (BMV:GENTERA) Share Prices Have Dropped 72% In The Last Five Years

Price target raised to Mex$12.45

New 90-day high: Mex$9.47

Third-quarter earnings released: Earnings miss expectations

New 90-day low: Mex$5.19

Third quarter earnings released

Price target lowered to Mex$12.31

Analysts update estimates

Analysts update estimates

Analysts update estimates

Price target lowered to Mex$13.71

New 90-day low - Mex$7.15

Analysts update estimates

Gentera, S.A.B. de C.V. (BMV:GENTERA *) agree to acquire 6% stake inConCredito- Bursatilizaciones de creditos from FinUtil, S.A. de C.V., Sofom ENR, Comfu S.A. de C.V and Talento ConCrédito for approximately MXN 510 million.

Price target lowered to Mex$14.83

New 90-day low - Mex$8.75

Gentera, S.A.B. de C.V. to Report Q2, 2020 Results on Jul 23, 2020

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse financiële instellingen

Ontdek gezonde bedrijven